Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Insider Transactions
    • Transcripts
    • AGM Invitations
  • inderesTV
  • Portfolio
  • Forum
  • Discovery
  • Premium
  • Femme
  • Nora AI
  • Learn
    • Investing School
    • Q&A
    • Analysis School
  • About Us
    • Our Coverage
    • Team
Log in to your Inderes Free account to see all free content on this page.
Create account

EQL Pharma

54.60 SEK

+0.74 %

Less than 1K followers

EQL

NASDAQ Stockholm

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data

Income statement

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for EQL Pharma

2019202020212022202320242025
Revenue50.072.0179.1409.8259.9264.2373.5
growth-%44.1 %148.7 %128.7 %-36.6 %1.6 %41.4 %
EBITDA3.47.311.438.841.332.667.4
EBIT-1.43.211.438.841.332.667.4
Profit before taxes-1.52.710.436.039.028.654.4
Net income-1.52.710.431.630.922.743.1
EPS-0.050.090.361.091.090.781.48
Dividend0.000.000.000.000.000.000.00
Dividend ratio-0.0 %0.0 %0.0 %0.0 %0.0 %0.0 %0.0 %
Login required

This content is only available for logged in users

Create account

Profitability and return on capital

2019202020212022202320242025
EBITDA-%6.8 %10.1 %6.4 %9.5 %15.9 %12.3 %18.0 %
EBIT-%-2.8 %4.4 %6.4 %9.5 %15.9 %12.3 %18.0 %
ROE-1.9 %3.3 %11.4 %25.5 %20.0 %12.8 %19.5 %
ROI-1.5 %2.2 %5.2 %13.3 %10.8 %6.1 %5.3 %
Login required

This content is only available for logged in users

Create account
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.